Endometriosis Clinical Trial
— EMPOWEROfficial title:
Endometriosis Diagnosis Using microRNA: Prospective Study in Women to Allow Early Disease Recognition
NCT number | NCT04598698 |
Other study ID # | DL-001 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | November 2, 2020 |
Est. completion date | September 2024 |
Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal risk study in women undergoing laparoscopy, laparotomy or other pelvic surgical procedure for endometriosis, infertility or another benign gynecological indication. Participants will undergo 2 study visits for collection of blood and saliva and completion of study questionnaires.
Status | Recruiting |
Enrollment | 750 |
Est. completion date | September 2024 |
Est. primary completion date | September 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 49 Years |
Eligibility | Inclusion Criteria: 1. Participant is willing and able to provide written informed consent. 2. Participant is willing and able to provide up to 50 mL of blood via venipuncture and comply with all other study and sample collection procedures. 3. Participant is a female aged 18 through 49 years (inclusive). 4. Participant is scheduled to undergo: 1. Laparotomy or laparoscopy for signs and symptoms of suspected endometriosis. This shall constitute approximately 95% of the participants enrolled. 2. Laparotomy, laparoscopy, or other procedures including, but not limited to, tubal ligation, lysis of adhesions, hysterectomy for benign condition, myomectomy, salpingo-oophorectomy, cystectomy, or diagnostic laparoscopy for indications including, but not limited to, infertility or benign gynecological indications (e.g., benign pelvic masses, infertility, abnormal uterine bleeding). This shall constitute approximately 5% of the participants enrolled. Exclusion Criteria: 1. Participant has a history of surgically determined diagnosis of endometriosis (either via visual inspection or histopathology). 2. Participant is a female in a pre-menarchal or post-menopausal state (last menstrual period at least 1 year before Screening and no other biological or physiological cause can be identified) or has been rendered surgically menopausal (bilateral oophorectomy) for at least 6 months at Screening. 3. Participant is pregnant. 4. Participant has an active malignancy. 5. Participant is known to have tested positive for human immunodeficiency virus or hepatitis A, B, or C. 6. Participant has an active pelvic infection or other infections contraindicated for surgery. 7. Participant has participated (±3 months of study enrollment) in a clinical trial where an investigational drug was or is planned to be administered. 8. Participant has any general health or behavioral condition that, in the opinion of the investigator, should exclude the participant from participation. |
Country | Name | City | State |
---|---|---|---|
United States | Academia of Women's Health and Endoscopic Surgery | Atlanta | Georgia |
United States | UT Austin | Austin | Texas |
United States | Johns Hopkins University | Baltimore | Maryland |
United States | Northwestern Medicine | Chicago | Illinois |
United States | Cleveland Clinic | Cleveland | Ohio |
United States | University Hospitals | Cleveland | Ohio |
United States | NorthShore University HealthSystem | Evanston | Illinois |
United States | Penn State Health | Hershey | Pennsylvania |
United States | University of Louisville Hospital | Louisville | Kentucky |
United States | Rutgers Robert Wood Johnson University Hospital | New Brunswick | New Jersey |
United States | Yale University | New Haven | Connecticut |
United States | NewYork-Presbyterian / Columbia University Medical Center | New York | New York |
United States | Christiana Care | Newark | Delaware |
United States | RAD Fertility | Newark | Delaware |
United States | University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma |
United States | Stanford University Hospital | Palo Alto | California |
United States | The Advanced Gynecologic Surgery Institute | Park Ridge | Illinois |
United States | Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania |
United States | University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania |
United States | Seattle Reproductive Medicine | Seattle | Washington |
United States | University of South Florida | Tampa | Florida |
United States | MedStar Washington Hospital Center | Washington | District of Columbia |
United States | Center for Special Minimally Invasive & Robotic Surgery | Woodside | California |
Lead Sponsor | Collaborator |
---|---|
Dot Laboratories, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical validity | Performance of a microRNA (miRNA)-based assay compared to visual inspection during surgery for the diagnosis of active endometriosis | From date of first sample collection to surgery, up to 3 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01931670 -
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
|
Phase 3 | |
Recruiting |
NCT05648669 -
A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain
|
Phase 3 | |
Completed |
NCT04081532 -
The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT06101303 -
Endometriosis Pain
|
||
Completed |
NCT04665414 -
Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
|
||
Completed |
NCT03690765 -
Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
|
||
Recruiting |
NCT05153512 -
ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
|
||
Active, not recruiting |
NCT04171297 -
Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
|
||
Recruiting |
NCT04172272 -
The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures
|
N/A | |
Completed |
NCT04565470 -
Strategies of Self-management of Endometriosis Symptoms
|
||
Completed |
NCT03613298 -
Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement.
|
N/A | |
Withdrawn |
NCT05568940 -
Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
|
||
Not yet recruiting |
NCT03464799 -
Does Immunotherapy Have a Role in the Management of Endometriosis?
|
||
Active, not recruiting |
NCT03002870 -
Characteristics of Patient Population With Endometriosis
|
N/A | |
Withdrawn |
NCT03272360 -
Endometriosis Biomarker Discovery Study
|
N/A | |
Completed |
NCT02973854 -
Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
|
||
Recruiting |
NCT02481739 -
Laparoscopic Surgical Management of Endometriosis on Fertility
|
N/A | |
Active, not recruiting |
NCT02754648 -
Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve
|
N/A | |
Completed |
NCT06106932 -
GnRH-a on Angiogenesis of Endometriosis
|
N/A | |
Completed |
NCT02387931 -
Supplementation in Adolescent Girls With Endometriosis
|
Phase 4 |